Cambridge Investment Research Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$375K Buy
3,608
+444
+14% +$47.3K ﹤0.01% 3072
2025
Q4
$326K Sell
3,164
-210
-6% -$20.4K ﹤0.01% 3117
2025
Q3
$305K Buy
3,374
+221
+7% +$19.4K ﹤0.01% 3099
2025
Q2
$277K Sell
3,153
-236
-7% -$20.5K ﹤0.01% 3051
2025
Q1
$309K Sell
3,389
-32
-0.9% -$2.88K ﹤0.01% 2845
2024
Q4
$295K Sell
3,421
-40,792
-92% -$3.69M ﹤0.01% 2845
2024
Q3
$4.2M Buy
44,213
+39,385
+816% +$3.74M 0.01% 902
2024
Q2
$442K Buy
4,828
+1,981
+70% +$177K ﹤0.01% 2392
2024
Q1
$258K Buy
+2,847
New +$249K ﹤0.01% 2827
2023
Q3
Sell
-9,802
Closed -$772K 3238
2023
Q2
$772K Buy
9,802
+3,228
+49% +$253K ﹤0.01% 1799
2023
Q1
$510K Sell
6,574
-20,019
-75% -$1.54M ﹤0.01% 2063
2022
Q4
$2.07M Buy
26,593
+23,339
+717% +$1.72M 0.01% 1061
2022
Q3
$219K Sell
3,254
-767
-19% -$56.5K ﹤0.01% 2626
2022
Q2
$309K Buy
+4,021
New +$314K ﹤0.01% 2359

Other funds holding PPH